Emergent BioSolutions' President Presents at the 30th Annual J.P. Morgan ... Seeking Alpha CD20 as you may know is a validated target for certain marketed products including Rituximab. This product is completely out-licensed to Pfizer. So Pfizer is responsible for all aspects of the development program. Therefore if successful we expect we ... |
